Guangzhou Hexin Instrument Hits Day High with 15.29% Surge

Guangzhou Hexin Instrument Co., Ltd. has experienced significant activity today, with the stock surging by 15.29% on October 30, 2025. The stock reached an intraday high of CNY 157.64, marking a notable performance against the backdrop of the China Shanghai Composite, which only increased by 0.7% on the same day.
Over the past week, Guangzhou Hexin has shown a robust performance, climbing 12.53%, and over the past month, it has surged by 43.78%. The company's year-to-date performance stands at an impressive 142.55%, while its one-year performance has skyrocketed by 393.65%, significantly outpacing the China Shanghai Composite's 22.21% increase.

Despite these gains, the company faces challenges, including operating losses and a weak long-term fundamental strength. The debt-to-equity ratio is at 0.57, indicating a high level of debt relative to equity. Additionally, recent financial results have shown a decline in net sales and pre-tax profit, raising concerns about the company's financial health. As a mid-cap player in the pharmaceuticals and biotechnology sector, Guangzhou Hexin's current trajectory reflects a complex interplay of performance metrics and underlying financial realities.